Outcomes, safety of weight-based bedaquiline in children with multidrug-resistant TB

Jessica Nye
May 6, 2022, 9:38 p.m.

Weight-based dosing of bedaquiline for multidrug/rifampicin-resistant (MDR/RR) tuberculosis (TB) infection was safe and effective among children with and without HIV coinfection, according to findings published in Clinical Infectious Diseases.

Read the full story at Infectious Disease Advisor.